Browse by field and institution
Biotechnology & Life Sciences at Stanford University (OTL)
Genetics, cell biology, biochemistry, microbiology and pharmaceutical preparations. The 207 Biotechnology & Life Sciences technologies Stanford University (OTL) markets for licensing, each joined to the patent record diligence turns on: who owns it now, whether it is still in force, and how many years of exclusive term remain.
| Published | Technology | Status | Owner | Expiry |
|---|---|---|---|---|
| 2026-04-28 | Chromatin-opening element for stable long term gene expression Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-04-05). |
| 2026-04-28 | Promoter specific for non-pigmented ciliary epithelial cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Assigned awayThe patent's current assignee of record is US Department of Veterans Affairs, not Stanford University (OTL); it appears to have been assigned away. Confirm licensing rights with the current owner. | Active termAbout 17.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-09-02). |
| 2026-04-28 | RNA replication using transcription polymerases Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-10-27). |
| 2026-04-21 | Combination therapy for cancer Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is United States Governmment Represented By Department Of Veterans Affairs AS, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 16.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-02-16). |
| 2026-04-14 | Compositions and methods for controlling production of polypeptides in cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 17.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-08-15). |
| 2026-03-31 | Method for multiplexed detection of nucleic acids using spectrally encoded beads Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-02-13). |
| 2026-03-31 | Directed evolution for obtaining improved variants of TEV protease for biotechnological applications Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-10-15). |
| 2026-03-31 | Enantiomer selective action on neurotransmission Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-04-28). |
| 2026-03-24 | Molecular targets for modulation of dissociative and associative states Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-10-20). |
| 2026-03-10 | Isoform-specific aldehyde dehydrogenase inhibitors Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-12-21). |
| 2026-03-10 | Aerosolized mucus-tethering nanobodies to protect against viral and microbial contamination in closed and semi-enclosed spaces Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-02-03). |
| 2026-03-03 | Hematopoietic stem cell engraftment with a combination of agents Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-05-17). |
| 2026-02-24 | Metabolic rescue of retinal degeneration Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 17.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-06-30). |
| 2026-02-24 | Controlled nutrient delivery to pancreatic islets using a novel mesoporous silica-based nanoparticle platform Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-04-27). |
| 2026-02-03 | Inhibitors of phospholipid synthesis and methods of use Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-01-18). |
| 2026-02-03 | Crispr-based FOXP3 gene engineered t cells and hematopoietic stem cell precursors to treat IPEX syndrome patients Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-03-26). |
| 2026-01-27 | Surface enhanced raman scattering nanoparticles and their use in detecting and imaging oxidative stress Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 17.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-05-31). |
| 2026-01-20 | Immolative cell-penetrating complexes for nucleic acid delivery Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-08-10). |
| 2026-01-13 | Methods and systems for multiplex gene amplification from ultra-low DNA input amounts and uses thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-08-12). |
| 2025-12-16 | Neuroprotection of neuronal soma and axon by modulating ER stress/UPR molecules Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-03-22). |
| 2025-12-09 | Tissue engineered 3D models for cancer metastasis Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-12-02). |
| 2025-11-18 | Chimeric antigen receptor polypeptides and methods of using same Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-05-22). |
| 2025-11-18 | Spectral imaging platform for infectious disease diagnosis Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-01-14). |
| 2025-11-04 | Blood-based signatures for diagnosis and sub-typing of inflammatory bowel disease subsets Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-12-22). |
| 2025-11-04 | Methods utilizing single cell genetic data for cell population analysis and applications thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-04-08). |
| 2025-10-28 | Regulatable cell surface receptors and related compositions and methods Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-09-02). |
| 2025-10-14 | Cross-reactive epitope for multiple sclerosis Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-02-15). |
| 2025-09-30 | Systems and temporal alignment methods for evaluation of gestational age and time to delivery Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 17.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-11-20). |
| 2025-09-16 | PI4-kinase inhibitors and methods of using the same Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-12-08). |
| 2025-09-16 | Multiplex production and barcoding of genetically engineered cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Brandeis University, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 13.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-01-20). |
| 2025-09-02 | Prophylactic skin treatment for radiation therapy Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-08-29). |
| 2025-08-19 | Methods of treatment, genetic screening, and disease models for heart conditions associated with RBM20 deficiency Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Europaisches Laboratorium fuer Molekularbiologie EMBL, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 16.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-11-16). |
| 2025-08-19 | Cryogel bioscaffold Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-05-28). |
| 2025-08-12 | Processes for genetic and clinical data evaluation and classification of complex human traits Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Assigned awayThe patent's current assignee of record is US Department of Veterans Affairs, not Stanford University (OTL); it appears to have been assigned away. Confirm licensing rights with the current owner. | Active termAbout 14.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-04-21). |
| 2025-08-05 | Lipid nanodiscs solubilized through poly(acrylic acid-co-styrene) copolymers Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Aarhus Universitet, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 16.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-06-29). |
| 2025-07-29 | Therapeutic antigen binding proteins specific for CD93 and methods of use thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-12-02). |
| 2025-07-08 | Therapeutic antibodies against osteopontin Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is US Department of Veterans Affairs, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 16.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-11-07). |
| 2025-07-01 | Method for determining if a tumor has a mutation in a microsatellite Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-01-12). |
| 2025-06-24 | Compositions and methods for treating protein aggregation-associated diseases Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is KONSTANZ, University of, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 15.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-04-10). |
| 2025-06-03 | Generation of type 1 regulatory T cells through transcription factor targeting Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 16.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-07-22). |
| 2025-05-20 | Epitope restriction for antibody selection Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-04-25). |
| 2025-04-15 | Near-infrared-II nanoparticles and related compositions and methods Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-03-26). |
| 2025-04-15 | Affibody proteins specific for B7-H3 (CD276) Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-01-13). |
| 2025-04-01 | Light-responsive polypeptides and methods of use thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Assigned awayThe patent's current assignee of record is University of Tokyo NUC, not Stanford University (OTL); it appears to have been assigned away. Confirm licensing rights with the current owner. | Active termAbout 16.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-06-21). |
| 2025-02-18 | Method to perform high-throughput single cell genomic and phenotypic analyses Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-06-12). |
| 2025-01-14 | Composition and method for new antimicrobial agents with secondary mode of action provided by conjugation of an antimicrobial to a guanidinium-rich molecular transporter Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-09-20). |
| 2025-01-07 | Pulsed focused ultrasound therapy for treatment of pancreatic disorders Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-04-24). |
| 2024-12-31 | Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-03-24). |
| 2024-12-10 | Antibodies against dengue virus and related methods Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-11-11). |
| 2024-11-05 | In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-10-01). |
| 2024-10-08 | Engineered promiscuous biotin ligases for efficient proximity labeling Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-02-02). |
| 2024-09-24 | Assessment of polygenic trait risk via trait components and applications thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-01-20). |
| 2024-09-10 | Frizzled specific Wnt agonists and antagonists Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is University of Washington, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 14.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-04-26). |
| 2024-07-30 | Soluble leukemia inhibitory factor receptor polypeptides and methods of using same for inhibiting leukemia inhibitory factor activity Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-01-28). |
| 2024-07-16 | Compositions and methods for in situ-forming tissue constructs Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Assigned awayThe patent's current assignee of record is US Government Represented By Department Of Veterans Affairs, not Stanford University (OTL); it appears to have been assigned away. Confirm licensing rights with the current owner. | Active termAbout 13.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-03-10). |
| 2024-06-04 | Functionalized nanoparticles and their use in treating bacterial infections Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-04-13). |
| 2024-05-14 | Methods for reversing HIV latency using BAF complex modulating compounds Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Erasmus University Medical Center, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 14.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-02-20). |
| 2024-04-09 | NIR-II imaging probe and methods of using the NIR-II imaging probe for dynamic in vivo tracking Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-11-14). |
| 2024-04-09 | Intranasal vasopressin treatment of social deficits in autism Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-10-17). |
| 2024-03-26 | Rewiring aberrant cancer signaling to a therapeutic effector response with a synthetic two-component system Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-07-19). |
| 2024-03-12 | Polymeric nanoparticles for enhanced cancer immunotherapy Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-07-27). |
| 2024-03-05 | Sensitization of cancer cells to differentiation therapy with mitochondrial uncoupler niclosamide ethanolamine Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-01-27). |
| 2024-02-20 | Genome editing of graft-derived T-cells for post-transplant immunotherapy Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-03-19). |
| 2024-02-06 | PDE5A destabilizing domains Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-05-14). |
| 2024-02-06 | Compositions and methods for treating age-related diseases Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Assigned awayThe patent's current assignee of record is US Department of Veterans Affairs, not Stanford University (OTL); it appears to have been assigned away. Confirm licensing rights with the current owner. | Active termAbout 12.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-12-21). |
| 2024-01-30 | Methods for detecting mycobacteria with solvatochromic dye conjugates Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-08-30). |
| 2023-11-28 | Measurement of afucosylated IgG Fc glycans and related vaccination methods Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-06-04). |
| 2023-10-31 | Light-responsive polypeptides and methods of use thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-11-28). |
| 2023-10-03 | N-hydroxyethyl didehydroazapodophyllotoxins as GBP1 inhibitors and methods of overcoming treatment resistance in cancer Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-05-23). |
| 2023-10-03 | Molecular vibrational spectroscopic markers for detection of cancer Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-10-01). |
| 2023-10-03 | CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous recombination of AAV donor vectors Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-11-27). |
| 2023-09-26 | Compositions and methods for nucleic acid expression and protein secretion in Bacteroides Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-02-02). |
| 2023-09-19 | High-throughput precision genome editing Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-12-20). |
| 2023-08-29 | Systems and methods to assess RNA stability Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-07-01). |
| 2023-08-22 | Small molecule CMKLR1 antagonists in inflammatory disease Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Assigned awayThe patent's current assignee of record is US Department of Veterans Affairs, not Stanford University (OTL); it appears to have been assigned away. Confirm licensing rights with the current owner. | Active termAbout 15.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-05-27). |
| 2023-08-22 | Systems and methods to identify transcription factor activation domains and uses thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-01-27). |
| 2023-07-18 | Inhibitors of phospholipid synthesis and methods of use Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-05-26). |
| 2023-06-27 | Treatment of cancer with combinations of agents Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-07-09). |
| 2023-06-20 | Caspase-3-triggered molecular self-assembling PET probes and uses thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-09-13). |
| 2023-06-06 | Diagnosis and regulation of epidermal differentiation and cancer cell activity Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-01-26). |
| 2023-05-30 | Robust quantification of single molecules in next-generation sequencing using non-random combinatorial oligonucleotide barcodes Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-10-29). |
| 2023-05-23 | Multiplex isotype-specific antibody detection Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-12-03). |
| 2023-05-16 | Profiling and treatment of MYC-associated cancers with NK cells and type 1 interferon Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-01-11). |
| 2023-03-28 | Accurate and sensitive unveiling of chimeric biomolecule sequences and applications thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-05-20). |
| 2023-03-21 | Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 14.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-04-25). |
| 2023-03-14 | Ultrabright lanthanide-doped nanoparticles Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-05-09). |
| 2023-02-28 | Methods and reagents for detection of chikungunya virus or chikungunya virus and dengue virus Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-09-22). |
| 2023-02-28 | Beta-2 selective adrenergic receptor agonists Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Friedrich Alexander Universitaet Erlangen Nuernberg, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 12.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-04-03). |
| 2023-02-07 | Photoreversible acylation reagents Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-09-25). |
| 2022-12-20 | Reversing deficient hedgehog signaling restores deficient skeletal regeneration Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-01-08). |
| 2022-12-20 | Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-06-03). |
| 2022-12-06 | Therapeutic agents specifically delivered by exosomes for cancer treatment Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-08-01). |
| 2022-11-08 | Systems and methods for producing RNA constructs with increased translation and stability Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 15.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-08-31). |
| 2022-11-01 | Collector device of environmental exposure for biotic and abiotic agents Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-10-02). |
| 2022-10-18 | Methods for treating triple-negative breast cancer Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-09-18). |
| 2022-10-11 | Nucleic acid quantification using concentration-specific barcodes Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-04-12). |
| 2022-08-16 | Enzastaurin and fragile histidine triad (FHIT)-increasing agents for the treatment of pulmonary hypertension Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-05-18). |
| 2022-06-28 | Prodrug derivatives of protein kinase C modulators Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-10-23). |
| 2022-04-05 | Manipulation of nuclear architecture Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is System Biosciences LLC, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 14.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2040-08-08). |
| 2021-11-16 | Compositions and methods to modulate chloride ion channel activity Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 13.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-06-21). |
| 2021-04-13 | Methods for identifying and treating cancer patients Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-05-21). |
| 2021-03-16 | VCAM-1 mediated methods and compositions for treating aging-associated impairments Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-11-18). |
| 2021-03-16 | Methods for enumeration of rare cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-04-27). |
| 2021-03-02 | Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-08-04). |
| 2021-02-16 | Methods for diagnosis of tuberculosis Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-08-10). |
| 2021-01-05 | Methods and systems for identification of biomolecule sequence coevolution and applications thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-08-03). |
| 2020-12-29 | Use of annexin V to reduce the spread of intracellular pathogens Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-07-03). |
| 2020-11-24 | Techniques for determining haplotype by population genotype and sequence data Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-12-01). |
| 2020-10-27 | Humanized and chimeric monoclonal antibodies to CD81 Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-06-14). |
| 2020-10-13 | Compositions and methods for multiplexed quantitative analysis of cell lineages Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-03-29). |
| 2020-09-29 | Producing mesodermal cell types and methods of using the same Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 9.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-04-20). |
| 2020-09-01 | Cartilage cells with a high regenerative potential and low immune response for use in cellular therapy Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-05-12). |
| 2020-08-18 | Ladderane lipid compounds and liposomes and methods of preparing and using the same Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-08-30). |
| 2020-08-18 | Techniques for determining whether an individual is included in ensemble genomic data Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-02-23). |
| 2020-06-09 | Nucleoside agents for the reduction of the deleterious activity of extended nucleotide repeat containing genes Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is National Yang Ming Chiao Tung University NYCU, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 9.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-05-18). |
| 2020-05-19 | Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-11-11). |
| 2020-04-28 | Methods and compositions for modulating AAV infection Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Oregon Health and Science University, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 10.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-11-09). |
| 2020-04-21 | Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is US Department of Veterans Affairs, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 4.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-01-28). |
| 2020-02-25 | Stabilized step function opsin proteins and methods of using the same Stanford University (OTL) | Expired - Fee RelatedExpired early due to an unpaid maintenance fee (US patents owe fees at 3.5, 7.5 and 11.5 years), not by reaching the end of its term. Such lapses can sometimes be revived. | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-04-23). |
| 2020-02-04 | Targeting pleiotrophin signaling to limit high-grade glioma invasion Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 12.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-08-15). |
| 2020-01-28 | Pericytes are intermediate progenitors for epicardial derived coronary artery smooth muscle Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-09-01). |
| 2020-01-28 | Replacement gene tolerizing vectors and methods of use thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-09-23). |
| 2019-12-24 | Methods, compounds, and compositions for anesthesia Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Assigned awayThe patent's current assignee of record is US Department of Veterans Affairs, not Stanford University (OTL); it appears to have been assigned away. Confirm licensing rights with the current owner. | Active termAbout 9.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-10-16). |
| 2019-12-03 | Enhanced microbial electrosynthesis by using co-cultures Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-04-09). |
| 2019-11-19 | Engineered light-activated anion channel proteins and methods of use thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-03-27). |
| 2019-11-05 | High resolution STR analysis using next generation sequencing Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-03-09). |
| 2019-11-05 | Quantification of mutant alleles and copy number variation using digital PCR with nonspecific DNA-binding dyes Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 9.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-08-27). |
| 2019-10-29 | Compositions and methods for increasing proliferation of adult salivary stem cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-09-06). |
| 2019-10-08 | Systems and methods for targeted therapy based on single-cell stimulus perturbation response Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-05-13). |
| 2019-10-08 | Dopamine receptor type 2 specific promoter and methods of use thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 9.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-12-03). |
| 2019-08-20 | Long term hematopoietic stem cell specific reporter mouse and uses thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-06-10). |
| 2019-08-13 | Method of treating glioma Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 9.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-01-29). |
| 2019-08-06 | Probes for rapid and specific detection of mycobacteria Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-10-14). |
| 2019-07-09 | Method and system for network modeling to enlarge the search space of candidate genes for diseases Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-05-29). |
| 2019-06-04 | Compositions and methods for controlling pain Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Circuit Therapeutics Inc, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 8.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-08-13). |
| 2019-05-14 | Spanning-tree progression analysis of density-normalized events (SPADE) Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-04-04). |
| 2019-04-30 | Emulsion-based fermentation for accelerated gas substrate mass transfer Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-03-26). |
| 2019-04-23 | High resolution imaging using near-infrared-II fluorescence Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-10-21). |
| 2019-03-26 | CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-11-29). |
| 2019-03-05 | Oxygen tolerant hydrogenase by mutating electron supply pathway Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-09-02). |
| 2019-03-05 | Injectable and stable hydrogels with dynamic properties modulated by biocompatible catalysts Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-10-12). |
| 2019-02-26 | Compositions and methods for treating medulloblastoma Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-06-08). |
| 2019-01-29 | Dual-modality imaging probe for combined localization and apoptosis detection of stem cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 11.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-08-04). |
| 2019-01-29 | Modulation of cellular DNA repair activity to intercept malignancy Stanford University (OTL) | Expired - Fee RelatedExpired early due to an unpaid maintenance fee (US patents owe fees at 3.5, 7.5 and 11.5 years), not by reaching the end of its term. Such lapses can sometimes be revived. | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-03-31). |
| 2019-01-15 | Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-02-16). |
| 2019-01-08 | Methods of treating heart failure with agonists of hypocretin receptor 2 Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-05-12). |
| 2018-11-27 | Use of photosynthesis to rebalance ischemia bioenergetics Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-08-30). |
| 2018-11-13 | Systems and methods for interpreting a human genome using a synthetic reference sequence Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-12-17). |
| 2018-10-09 | Blockade of RGMb for reducing transplantation-associated immune responses Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-11-03). |
| 2018-10-02 | SIRP alpha-antibody fusion proteins Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 9.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-08-07). |
| 2018-08-07 | Humanized and chimeric monoclonal antibodies to CD99 Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-04-17). |
| 2018-06-26 | Non-silencing selectable marker genes and methods of use Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 9.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-02-19). |
| 2018-04-03 | Site-specific integration of transgenes into human cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 9.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-08-07). |
| 2018-03-06 | Cyan-excitable orange-red fluorescent proteins and bioluminescent resonance energy transfer systems Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 10.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-07-21). |
| 2018-02-27 | Amphipathic co-oligomers for the delivery of siRNA Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-03-27). |
| 2017-12-19 | Immuno imaging agent for use with antibody-drug conjugate therapy Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Sanofi SA, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 7.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-04-09). |
| 2017-11-14 | Methods for treating cancer by activation of BMP signaling Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-11-13). |
| 2017-07-04 | Peptide vaccines based on the EGFRvIII sequence for the treatment of tumors Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-08-02). |
| 2017-06-20 | Methods of improving microvascular integrity Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Legacy Pharma Inc Sezc, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 7.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-03-13). |
| 2017-05-23 | Inhibition of focal adhesion kinase for control of scar tissue formation Stanford University (OTL) | Expired - Fee RelatedExpired early due to an unpaid maintenance fee (US patents owe fees at 3.5, 7.5 and 11.5 years), not by reaching the end of its term. Such lapses can sometimes be revived. | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-12-14). |
| 2017-03-28 | Fluorescent protein voltage sensors for measuring membrane potential and imaging high-frequency neuronal electrical activity Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 8.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-01-22). |
| 2017-01-31 | Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 4.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-03-21). |
| 2016-10-11 | Pluripotent cell lines and methods of use thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Tyler Medical Research LLC, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 3.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2029-06-24). |
| 2016-10-11 | Ex vivo culture, proliferation and expansion of intestinal epithelium Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 5.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-09-05). |
| 2016-08-30 | tRNA derived small RNAs (tsRNAs) involved in cell viability Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-03-14). |
| 2016-08-09 | Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-03-13). |
| 2016-08-02 | Macroporous 3-D scaffolds for tissue engineering Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-07-16). |
| 2016-05-24 | Mini-intronic plasmid vectors Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-01-17). |
| 2016-04-12 | Direct capture, amplification and sequencing of target DNA using immobilized primers Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-10-19). |
| 2016-03-15 | Mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from Natromonas pharaonis (NpHR) Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 1.7 years of exclusive term remain as of 2026-06-06 (expected expiration 2028-03-03); a short runway. |
| 2016-03-15 | Monodisperse random coil proteins and bioconjugates thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-08-28). |
| 2016-03-01 | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 0.1 years of exclusive term remain as of 2026-06-06 (expected expiration 2026-07-24); a short runway. |
| 2016-02-23 | Compositions and methods for treatment of mitochondrial diseases Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-03-25). |
| 2016-02-02 | Expression vector comprising a nucleotide sequence encoding a Volvox carteri light-activated ion channel protein (VChR1) and implantable device thereof Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 3.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2029-07-03). |
| 2016-01-19 | Optical tissue interface method and apparatus for stimulating cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 0.6 years of exclusive term remain as of 2026-06-06 (expected expiration 2027-01-25); a short runway. |
| 2016-01-12 | Chemically defined production of cardiomyocytes from pluripotent stem cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-12-31). |
| 2016-01-12 | Measurement and comparison of immune diversity by high-throughput sequencing Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 4.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-05-06). |
| 2016-01-05 | Methods and compositions for treating or preventing narcotic withdrawal symptoms Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-12-20). |
| 2015-12-15 | Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is National Yang Ming Chiao Tung University NYCU, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 5.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-06-22). |
| 2015-11-24 | Measuring and monitoring of cell clonality Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-10-30). |
| 2015-11-17 | System for optical stimulation of target cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 1.6 years of exclusive term remain as of 2026-06-06 (expected expiration 2028-01-10); a short runway. |
| 2015-11-10 | Mechanical biomarkers for oocyte and embryo viability Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-08-18). |
| 2015-11-03 | Depletion of teratoma-forming pluripotent stem cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 5.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-11-19). |
| 2015-10-27 | AAV capsid proteins for nucleic acid transfer Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-07-22). |
| 2015-07-14 | Light-sensitive ion-passing molecules Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 4.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-05-03). |
| 2015-06-23 | Process for the selection of PHB-producing methanotrophic cultures Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-05-11). |
| 2015-06-16 | Method of preparing RNA from ribonuclease-rich sources Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-08-21). |
| 2015-06-16 | Direct conversion of cells to cells of other lineages Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 4.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-01-19). |
| 2015-04-21 | Compounds and methods of making compounds Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-01-14). |
| 2015-02-24 | Method of making induced pluripotent stem cell from adipose stem cells using minicircle DNA vectors Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 5.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-04-06). |
| 2015-02-03 | Mutations in the LNK gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 7.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-07-25). |
| 2014-09-02 | Interpenetrating polymer network hydrogel Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 1.3 years of exclusive term remain as of 2026-06-06 (expected expiration 2027-10-07); a short runway. |
| 2014-07-01 | Star polymers, methods of preparation thereof, and uses thereof Stanford University (OTL) | Expired - Fee RelatedExpired early due to an unpaid maintenance fee (US patents owe fees at 3.5, 7.5 and 11.5 years), not by reaching the end of its term. Such lapses can sometimes be revived. | Third partyThe patent's current assignee of record is International Business Machines Corp, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 6.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-10-15). |
| 2014-06-10 | RNA interactome analysis Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 6.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-08-07). |
| 2013-04-09 | Administration of FGF2 for treamtent of anxiety Stanford University (OTL) | Expired - Fee RelatedExpired early due to an unpaid maintenance fee (US patents owe fees at 3.5, 7.5 and 11.5 years), not by reaching the end of its term. Such lapses can sometimes be revived. | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 0.2 years of exclusive term remain as of 2026-06-06 (expected expiration 2026-08-10); a short runway. |
| 2012-12-25 | Derivation of neural stem cells from embryonic stem cells Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 5.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-08-24). |
| 2012-10-23 | Methods and compositions for performing low background multiplex nucleic acid amplification reactions Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 3.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2029-06-26). |
| 2012-08-21 | Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Massachusetts Institute of Technology, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Expiring soonOnly about 0.8 years of exclusive term remain as of 2026-06-06 (expected expiration 2027-03-20); a short runway. |
| 2012-08-07 | Minicircle DNA vector preparations and methods of making and using the same Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 3.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2030-05-18). |
| 2012-05-08 | Method for regulating protein function in cells using synthetic small molecules Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 2.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2028-11-06). |
| 2012-03-06 | Minigene expression cassette Stanford University (OTL) | Expired - Fee RelatedExpired early due to an unpaid maintenance fee (US patents owe fees at 3.5, 7.5 and 11.5 years), not by reaching the end of its term. Such lapses can sometimes be revived. | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 0.8 years of exclusive term remain as of 2026-06-06 (expected expiration 2027-03-30); a short runway. |
| 2011-05-10 | Oligocarbonate molecular transporters Stanford University (OTL) | Active - ReinstatedIn force, but previously lapsed and reinstated -- confirm its current standing and fee history. | Third partyThe patent's current assignee of record is International Business Machines Corp, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Active termAbout 3.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2029-07-14). |
| 2011-05-10 | Polynucleotide encoding luciferase Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is University of California Berkeley, not Stanford University (OTL). Confirm licensing rights with the assignee of record. | Expiring soonOnly about 1.2 years of exclusive term remain as of 2026-06-06 (expected expiration 2027-08-01); a short runway. |
| 2011-03-29 | Methods and compositions for use in analyte detection using proximity probes Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 0.2 years of exclusive term remain as of 2026-06-06 (expected expiration 2026-08-18); a short runway. |
| 2011-02-15 | Bacterial poly(hydroxy alkanoate) polymer and natural fiber composites Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Active termAbout 3.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2029-07-09). |
| 2010-03-30 | Compositions and methods for diagnosing and treating neuropsychiatric disorders Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 0.9 years of exclusive term remain as of 2026-06-06 (expected expiration 2027-05-16); a short runway. |
| 2009-09-15 | AAV capsid library and AAV capsid proteins Stanford University (OTL) | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (Stanford University (OTL)). | Expiring soonOnly about 0.8 years of exclusive term remain as of 2026-06-06 (expected expiration 2027-03-30); a short runway. |
The Owner column flags when a patent's current assignee of record is not the marketing institution (a "Third party" or "Assigned away" tag means you may not be able to license it from that university). The Expiry column reads how much exclusive patent term remains: an "Expiring soon" or "Expired" tag means little or no exclusivity is left, whatever the listing says. Hover any tag for detail; click any column header to sort.